Greg Zante Viking Therapeutics, Inc. (VKTX) insider trading activity

Greg Zante is Chief Financial Officer of Viking Therapeutics, Inc.. Currently has a direct ownership of 174,854 shares of VKTX, which is worth approximately $11.7 Million. The most recent transaction as insider was on May 03, 2024, when has been sold 66,756 shares (Common stock, par value $0.00001 per share) at a price of $74.87 per share, resulting in proceeds of $4,998,021. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K

3.25% 3M change

17.13% 12M change

Total Value Held $11.7 Million

GREG ZANTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2024	SELL Open market or private sale	$4,998,021 $74.87 p/Share	66,756 Reduced 27.63%	174,854 Common stock, par valu...
May 03 2024	BUY Exercise of conversion of derivative security	$163,710 $4.78 p/Share	34,249 Added 12.42%	241,610 Common stock, par valu...
Mar 27 2024	SELL Payment of exercise price or tax liability	$1,384,277 $83.34 p/Share	16,610 Reduced 7.42%	207,361 Common stock, par valu...
Mar 27 2024	BUY Grant, award, or other acquisition	-	31,667 Added 12.39%	223,971 Common stock, par valu...
Mar 01 2024	SELL Payment of exercise price or tax liability	$1,712,325 $85.22 p/Share	20,093 Reduced 9.46%	192,304 Common stock, par valu...
Mar 01 2024	BUY Grant, award, or other acquisition	-	31,667 Added 12.97%	212,397 Common stock, par valu...
Jan 04 2024	SELL Payment of exercise price or tax liability	$257,741 $18.58 p/Share	13,872 Reduced 6.62%	195,730 Common stock, par valu...

Jan 04 2024	SELL Open market or private sale	$268,500 $17.9 p/Share	15,000 Reduced 7.66%	180,730 Common stock, par valu...
Jan 03 2024	SELL Payment of exercise price or tax liability	$854,722 $17.4 p/Share	49,122 Reduced 18.99%	209,602 Common stock, par valu...
Jan 03 2024	BUY Grant, award, or other acquisition	-	98,334 Added 29.02%	240,491 Common stock, par valu...
Apr 17 2023	SELL Open market or private sale	$150,000 $20.0 p/Share	7,500 Reduced 4.78%	149,279 Common stock, par valu...
Apr 17 2023	BUY Exercise of conversion of derivative security	$98,025 $13.07 p/Share	7,500 Added 4.57%	156,779 Common stock, par valu...
Apr 12 2023	SELL Open market or private sale	$747,792 $18.0 p/Share	41,544 Reduced 21.77%	149,279 Common stock, par valu...
Apr 12 2023	BUY Exercise of conversion of derivative security	$282,083 $6.79 p/Share	41,544 Added 17.88%	190,823 Common stock, par valu...
Apr 11 2023	SELL Open market or private sale	$1,013,310 $18.0 p/Share	56,295 Reduced 27.38%	149,279 Common stock, par valu...
Apr 11 2023	BUY Exercise of conversion of derivative security	$325,385 $5.78 p/Share	56,295 Added 21.5%	205,574 Common stock, par valu...
Apr 03 2023	SELL Open market or private sale	$556,398 $18.0 p/Share	30,911 Reduced 17.3%	147,778 Common stock, par valu...
Apr 03 2023	SELL Payment of exercise price or tax liability	$969,266 $17.57 p/Share	55,166 Reduced 26.98%	149,279 Common stock, par valu...
Apr 03 2023	BUY Exercise of conversion of derivative security	$240,178 $7.77 p/Share	30,911 Added 14.75%	178,689 Common stock, par valu...
Apr 03 2023	BUY Grant, award, or other acquisition	-	56,667 Added 21.7%	204,445 Common stock, par valu...
Mar 30 2023	SELL Open market or private sale	$2,227,493 $17.0 p/Share	131,029 Reduced 47.0%	147,778 Common stock, par valu...
Mar 30 2023	BUY Exercise of conversion of derivative security	$585,937 $6.25 p/Share	93,750 Added 25.16%	278,807 Common stock, par valu...
Jan 04 2023	SELL Payment of exercise price or tax liability	$174,361 $8.42 p/Share	20,708 Reduced 10.06%	185,057 Common stock, par valu...
Jan 03 2023	SELL Payment of exercise price or tax liability	$203,909 $8.52 p/Share	23,933 Reduced 10.42%	205,765 Common stock, par valu...
Jan 03 2023	BUY Grant, award, or other acquisition	-	90,667 Added 28.3%	229,698 Common stock, par valu...

Greg Zante

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VKTX shares.

Notify only if

Value

Insider Trading

Get notified when an Viking Therapeutics, Inc. insider buys or sells VKTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Viking Therapeutics, Inc.

Track Activities on VKTX

Account